Outset Medical (OM) saw its shares surge in the last session with trading volume being higher than average. The latest trend ...

Appoints Medical Technology Veteran Karen N. Prange to Board of DirectorsSAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset ...

The average one-year price target for Outset Medical (NasdaqGS:OM) has been revised to $11.98 / share. This is a decrease of ...

Revenue for 2025 is projected to be between $115 million and $125 million, with expectations of console growth and recurring revenue expansion. Gross margins for 2025 are expected to be in the high 30 ...

Outset said that it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in the United States. “With the FDA’s clearance of TabloCart with ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener The latest update ...

Outset Medical, Inc. has appointed Renee Gaeta as its new Chief Financial Officer, effective immediately, succeeding Nabeel Ahmed who is leaving for other opportunities. Gaeta brings extensive ...

Detailed price information for Outset Medical Inc (OM-Q) from The Globe and Mail including charting and trades.

Secures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt In addition, Outset has entered into a credit agreement and guaranty with a fund managed by ...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Outset Medical, Inc.

Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today ...